Patent No. EP1698630 (titled "New Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations") was filed by Alfasigma on Mar 3, 2005. The application was issued on Sep 3, 2014.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| SANDOZ | Jun 3, 2015 | TER MEER UND PARTNER |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Dec 4, 2020
Dec 3, 2020
Nov 27, 2020
Nov 27, 2020
Nov 26, 2020
Nov 26, 2020
Nov 25, 2020
Nov 25, 2020
Nov 20, 2020
Nov 20, 2020
Nov 6, 2020
Nov 3, 2020
Nov 3, 2020
Nov 3, 2020
Aug 27, 2020
Aug 27, 2020
May 14, 2020
May 11, 2020
May 8, 2020
May 7, 2020
May 7, 2020
May 7, 2020
May 7, 2020
May 5, 2020
Apr 30, 2020
Apr 30, 2020
Apr 30, 2020
Apr 30, 2020
Apr 28, 2020
Apr 28, 2020
Apr 21, 2020
Nov 14, 2018
Jul 30, 2018
Jul 23, 2018
Jan 29, 2018
Jan 23, 2018
Jan 23, 2018
Dec 14, 2017
Dec 12, 2017
Nov 30, 2017
Nov 30, 2017
Nov 30, 2017
Nov 30, 2017
Aug 17, 2017
Aug 3, 2017
Aug 3, 2017
Jul 20, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
Jul 6, 2017
May 4, 2017
Apr 20, 2017
Apr 18, 2017
Apr 18, 2017
Mar 9, 2017
Mar 8, 2017
Mar 7, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Mar 6, 2017
Feb 9, 2017
Feb 8, 2017
Feb 8, 2017
Feb 8, 2017
Feb 8, 2017
Feb 7, 2017
Feb 2, 2017
Feb 2, 2017
Feb 2, 2017
Feb 2, 2017
Feb 2, 2017
Jan 25, 2017
Jan 25, 2017
Jan 25, 2017
Jan 25, 2017
Jan 25, 2017
Dec 20, 2016
Dec 16, 2016
Dec 16, 2016
Dec 14, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 9, 2016
Dec 7, 2016
Dec 7, 2016
Dec 7, 2016
Dec 7, 2016
Jul 5, 2016
Jul 5, 2016
Jul 4, 2016
Jul 4, 2016
Jul 1, 2016
Jul 1, 2016
Jul 1, 2016
Jul 1, 2016
Jul 1, 2016
Jul 1, 2016
Jul 1, 2016
Jun 23, 2016
Apr 15, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Mar 23, 2016
Jan 7, 2016
Jan 7, 2016
Dec 21, 2015
Oct 21, 2015
Oct 21, 2015
Oct 12, 2015
Jul 28, 2015
Jul 28, 2015
Jul 15, 2015
Jul 13, 2015
Jul 13, 2015
Jul 13, 2015
Jun 12, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Jun 3, 2015
Sep 3, 2014
Aug 7, 2014
Jul 30, 2014
Jul 25, 2014
Jul 22, 2014
Jul 22, 2014
Jul 22, 2014
Jul 22, 2014
May 22, 2014
May 22, 2014
May 22, 2014
May 22, 2014
Apr 9, 2014
Nov 14, 2013
Nov 14, 2013
Nov 13, 2013
Nov 13, 2013
Nov 13, 2013
Nov 13, 2013
Nov 6, 2013
Jul 31, 2013
Jul 31, 2013
May 4, 2012
May 23, 2011
May 23, 2011
Apr 20, 2011
Mar 25, 2011
Mar 25, 2011
Feb 28, 2011
Feb 25, 2011
Feb 23, 2011
Jan 19, 2011
Jan 19, 2011
Sep 2, 2009
Sep 2, 2009
Sep 2, 2009
Sep 2, 2009
Sep 1, 2009
Sep 1, 2009
Sep 1, 2009
May 7, 2009
May 7, 2009
Feb 19, 2008
Feb 19, 2008
Feb 19, 2008
Feb 18, 2008
Feb 18, 2008
Dec 7, 2007
Dec 7, 2007
Nov 15, 2007
Oct 9, 2007
Oct 9, 2007
Nov 3, 2006
Oct 18, 2006
Sep 11, 2006
Sep 7, 2006
Aug 9, 2006
Aug 3, 2005
Aug 3, 2005
Aug 2, 2005
Apr 21, 2005
Apr 21, 2005
Mar 24, 2005
Mar 3, 2005
Mar 3, 2005
Mar 3, 2005
Mar 3, 2005
Mar 3, 2005